Aditxt, Inc. Sale Leaseback Transaction, Other Payments Required
Aditxt, Inc. (ADTX) reported Sale Leaseback Transaction, Other Payments Required of $25.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Notes › Leases
us-gaap:SaleLeasebackTransactionOtherPaymentsRequired · last filed 2024-04-16
- Aditxt, Inc. sale leaseback transaction, other payments required for the quarter ending 2023-06-30 was $0.00.
- Aditxt, Inc. sale leaseback transaction, other payments required for the quarter ending 2023-03-31 was $25.00K.
- Aditxt, Inc. sale leaseback transaction, other payments required for fiscal 2023 was $25.00K, a 0.00% change from fiscal 2022.
- Aditxt, Inc. sale leaseback transaction, other payments required for fiscal 2022 was $25.00K.
| Period end | Sale Leaseback Transaction, Other Payments Required 3 month | Sale Leaseback Transaction, Other Payments Required 6 month | Sale Leaseback Transaction, Other Payments Required 12 month |
|---|---|---|---|
| 2023-12-31 | $25.00K 10-K · filed 2024-04-16 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $25.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $25.00K 10-Q · filed 2023-05-15 | ||
| 2022-12-31 | $25.00K 10-K · filed 2023-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |